Immunic, Inc. (IMUX)
1.15
-0.05
(-4.17%)
USD |
NASDAQ |
Mar 18, 15:55
Immunic Total Liabilities (Quarterly) : 30.72M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BioRestorative Therapies, Inc. | 3.436M |
| Quince Therapeutics, Inc. | 108.84M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Agenus, Inc. | 504.66M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 24.05M |
| Shareholders Equity (Quarterly) | -6.673M |
| Debt to Equity Ratio | -0.0865 |
| Current Ratio | 0.7469 |
| Net Debt Paydown Yield | 0.10% |